SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-20-002184
Filing Date
2020-03-31
Accepted
2020-03-31 12:52:25
Documents
4
Period of Report
2020-05-12
Effectiveness Date
2020-03-31

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_033120.htm DEF 14A 962273
2 GRAPHIC logo.jpg GRAPHIC 5374
3 GRAPHIC proxy_1.jpg GRAPHIC 1782316
4 GRAPHIC proxy_2.jpg GRAPHIC 958511
  Complete submission text file 0001171843-20-002184.txt   4745425
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 20760699
SIC: 2836 Biological Products, (No Diagnostic Substances)